Skip to main content

'Nobody Speaks for the End Users'

Mary at The OpenHelix Blog — hosted by the genomics research resource firm — applauds the National Human Genome Reseach Institutes' efforts to plan for "sustainable exponential growth,""focus on democratization," and "spur better software development," (via Sean Eddy at Cryptogenomicon) but says that no one "really speaks for the consumers of this software and this data." Specifically, Mary writes, beyond question-and-answer style feedback systems and marker papers, "nobody speaks for the end users." The blogger says she'd like to see enhanced outreach efforts, and that they be required — though she doesn't suggest by whom. "No matter how much hardware and documentation you throw at these projects, if people don't know it exists, and have no idea how to use it, the project will not yield all the results that it could," Mary writes, adding that outreach should be standard procedure for software and database projects, "not an afterthought."

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.